Вы находитесь на странице: 1из 8

ANALYTICAL METHOD

DEVELOPMENT AND
METHOD VALIDATION OF
pH INDEPENDENT
ATORVASTATIN CALCIUM BY
UV-VISIBLE
SPECTROSCOPIC METHOD

DRUG PROFILE
Molecular formula: (C33H34FN2O5)2Ca.3H2O
Molecular weight: 1209.42
Nature of the drug and pharmaceutical
action:
Synthetic
cholesterol-lowering
agent and also called HMG-CoA(3-hydroxy3-methylglutaryl-coenzyme-coenzyme A)

ANALYTICAL METHOD DEVELOPMENT


Wavelength of the drug sample: 246.4nm
Selection of liquid diluent: ethyl alcohol of
AR-grade
which
is
cent
percent
satisfactory to be used as diluent
Instrument utilised: SHEMADZU-1700 UV
Vis spectrophotometer

100mg drug in 100ml


C2H5OH(1000g/ml consent)

10% dilution of drug solution to get the


concentration of 100g/ml solution.

Preparation of individual concentrations


i.e. 20,30,40 & 50g/ml solution.

ANALYTICAL METHOD VALIDATION OF


PURE DRUG
Validation
protocol
to
perform
following analytical method validation
through USP:

RESULTS
%RSD is 0.565% (in case of system
precision): satisfactory result.
In method precision %RSD is 0.17%
which is passed.
Linearity shows correlation
coefficient= 1
Ruggedness.

SUMMARY & CONCLUSION


This method which is developed
is well precise, well rugged, well
robust, simple as well as very
precise
one
which
obeys
satisfactory linear results.

REFERENCES
U.S. FDA Guidance for Industry
(draft) Analytical
Procedures

Вам также может понравиться